The latest press releases from The Jackson Laboratory
Includes licensing of custom Heligenics Gene Mutation/Function ERBB2 library for the JAX Clinical Knowledgebase.
The Jackson Laboratory (JAX) today announced that Daniel “Dan” R. Hoag, J.D. has been appointed general counsel and corporate secretary. He will assume the post on May 10, 2021 and will be based at the organization’s Farmington, Connecticut campus.
The Jackson Laboratory is a proud sponsor of the Connecticut Science & Engineering Fair This year, more than $350,000 in scholarships and prizes were awarded to top-ranking students.
The Jackson Laboratory (JAX) and the MDI YMCA have mutually agreed to discontinue plans for the construction of a childcare facility on the YMCA site in Bar Harbor.
The Alzheimer's Association awarded a grant to Jackson Laboratory researchers, Gareth Howell, Ph.D. and Kristen Onos, Ph.D., for their work deciphering microglial responses to amyloid and tau with wild-derived mice.
JDRF has announced the launch of the JDRF Center of Excellence in New England. The new center is comprised of a team of experts from institutions in New England including JAX’s Lenny Shultz, Ph.D.
Grant recipients were revealed live and announced by current players from the National Football League who have been engaged with Uplifting Athletes since college.
A new research affiliation agreement between Shriners Hospitals for Children (SHC) and JAX will endeavor to gain a greater understanding of the genetic factors involved in cerebral palsy.
The Maine State Science Fair (MSSF) took place virtually on April 3, 2021. 157 students representing 23 schools in 8 Maine counties tuned in to present virtual research or engineering projects to a panel of judges and attend events, competing for prestigious state titles and over $1 million in scholarships and awards.
In a forthcoming study, researchers will show that different strains of mice with hACE2 exhibit different COVID-19 pathologies.
Research that will provide valuable insights about how vaccines affect immune systems
The Jackson Laboratory (JAX) has appointed three faculty members to endowed chairs in order to further research into Alzheimer’s disease, addiction, cancer and computational biology.
Exactly 20 years after the successful completion of the "Human Genome Project," an international group of researchers, the Human Genome Structural Variation Consortium (HGSVC), has now sequenced 32 human genomes at high resolution.
JAX diabetes researcher explores the genetic variations that influence susceptibility to insulin resistance and type 2 diabetes.
Nadia Rosenthal joins international team to study the immune system’s effects on the heart’s connective tissue.
While Connecticut's vaccine rollout is progressing successfully, with the state ranking fifth nationally for the highest percent of the population vaccinated, continued public testing and caution are still more important than ever.
In 2020, The Jackson Laboratory was awarded over $100M in new federal, peer-reviewed foundation, and other grant funding to propel the research and education programs essential to its mission to improve human health.
British Heart Foundation funds research aimed at supporting the lymphatic system to prevent heart failure.
National Cancer Institute grant to JAX funds multi-pronged approach to address triple-negative breast cancers.
JAX’s Maine Cancer Genomics Initiative joins nationwide TAPUR Study, providing access to targeted cancer therapies for rural population.
The Hartford Business Journal has recognized JAX among its 2020 Health Care Heroes in the Innovation category, recognizing an organization that has made a positive advancement in medical care or medical science.
JAX supporter Diana Davis Spencer says her entrepreunerial spirit and passion for philanthropy are what motivate her to give.
JAX has recently developed two new genetic mouse models to be used in SETBP1 rare disease research.
Connecticut Technology Council award recognizes excellence in science and technology professions.
Second NIH contract to JAX will expand cell lines for studies of Alzheimer’s disease and related dementias.
Employee perk or privacy hazard? NIH funds JAX-co-led study to explore the ethical, legal, social, policy implications.
Newly re-funded JAX center is empowering innovative approaches to aging research.
Funding will support scientific research and training activities in the field of neurodegenerative diseases of the eye, including graduate and postdoctoral fellowship training and research projects in glaucoma, age-related macular degeneration, and ocular signs of Alzheimer’s disease.
The Maine Cancer Genomics Initiative (MCGI), a collaboration aimed at making the latest personalized medicine available to cancer patients throughout Maine, will now bring new precision oncology clinical trials to the state, support access to targeted therapies for patients not eligible for trials, and develop novel technology to enhance genomic education and genetic services through online platforms.
A budding genomics education program will expand to teachers nationwide through the creation of an online course in personal genomics for high school STEM educators.
New five-year NIH grant totaling $10.6M funds JAX center to fast-track treatment-focused research for rare genetic disorders.
Logan Schwartz, a student in the joint Tufts-JAX PhD program, has received an NIH service award.
JAX Professor Bob Braun has received new funding to study the genetic factors involved in spermatogonial stem cell turnover and maintenance, a vital aspect of human fertility.
The posdoctorate associate researchers were selected based on their cutting-edge research and exemplifying a well-rounded 21st-century member of the scientific community.
A saliva-based COVID-19 laboratory diagnostic test developed by researchers at the Yale School of Public Health has been granted an emergency use authorization by the U.S. Food and Drug Administration (FDA).
National Cancer Institute grant to JAX will fund the development of new tools to identify and analyze structural variants and their functional impacts in tumors.
A $2.4M National Institute on Aging grant will fund new JAX research in age-related blood condition.
Five-year, $2.1 million federal grant to Olga Anczuków of JAX will reveal the role of splicing-factor defects in cardiac or neurological disorders, cancer, and more.
NIDA grant to Vivek Kumar of JAX will fund development of new preclinical models of addiction.
The Jackson Laboratory (JAX) is excited to announce the recipients of its 2020 JAX College Scholarship: Ariel Le of Stratford, Connecticut, and Liz Schotten of Bath, Maine.
Bryan Robinson has been appointed vice president for advancement at JAX.
Testing protocols are likely to include screening thousands of out-of-state and resident hall students, identifying and isolating incidents of COVID-19 infection and protecting at-risk populations before classes begin.
The Jackson Laboratory (JAX), a nonprofit biomedical research institution, announced today the appointment of Brian O’Rourke as senior director of global security. O’Rourke will oversee security and safety for the institution’s workforce and campuses which includes more than 2,300 employees in Bar Harbor and Ellsworth, Maine; Farmington, Conn.; Sacramento, Calif. and Shanghai, China.
The Jackson Laboratory and Puritan Medical Products have partnered with Maine Maritime Academy to ensure the safety of students and crew during their simulated training cruise in Castine.
A generous gift from Jackson Laboratory (JAX) donors will support the development of new humanized mouse models for beating COVID-19, the infectious disease caused by the novel coronavirus that has infected over 7 million worldwide, killing over 400,000 people.
The project will be led by Yale University in collaboration with The Jackson Laboratory, Gallup, and Quest Diagnostics.
In partnership with the State of Connecticut, JAX is expanding its COVID-19 testing capacity from 550 tests per day to 20,000 tests per day, between now and early July for Connecticut residents.
JAX's Cancer Center designation has been renewed for the 34th year by the National Cancer Institute.
Town of West Hartford and The Jackson Laboratory announce a new collaboration designed to improve COVID-19 testing for West Hartford public safety.
JAX researchers are partnering up with scientists at UConn Health to develop a training program for the next generation of genomic scientists.
JAX has announced the appointment of Emily Schorer as chief human resources officer (CHRO).
JAX is now providing additional coronavirus testing capacity for frontline health care workers and in-patients in the state of Maine.
MGI website offers comprehensive information on coronavirus-related mouse models and research.
The 74th annual Maine State Science Fair (MSSF), organized by The Jackson Laboratory and Maine Mathematics and Science Alliance, took place virtually March 28. The winners were announced during a virtual award ceremony and are listed here.
The Jackson Laboratory for Genomic Medicine, in partnership with the Connecticut Department of Health, UConn Health and Hartford HealthCare, will provide additional coronavirus testing capacity for Connecticut residents
Prestigious five-year grant funds evolutionary genomics research, educational outreach.
ISCB honors JAX Professor Judith Blake for outstanding contributions to biology
JAX receives $6.1M, 5-year NIH grant for laboratory mouse resource program.
Jackson Laboratory (JAX) Assistant Professor Sheng Li, Ph.D., was chosen as a 2020 NextGen Star by the American Association for Cancer Research (AACR). She is one of 12 early-career cancer researchers recognized for their outstanding work and future potential.
Continuing in its mission to provide unsurpassed genetic quality and high health standards for mice, The Jackson Laboratory (JAX) has made several updates to the health reports. These changes include results for several newly tested organisms, updated organism names, and reorganized locations for the listed organisms in the health report.
William "Bill" Pierce has joined JAX as chief information officer (CIO) and Stephanie Wasco has been promoted to chief communications officer (CCO).
Shriners Hospitals for Children and The Jackson Laboratory announce research affiliation for genomic studies of pediatric patients.
The Jackson Laboratory, The Children’s Cancer Therapy Development Institute, and Champions Oncology offer rapid, cost-effective services to the pharma, biopharma and biotech industry, speeding the right drug to the right pediatric cancer whenever possible.
The Jackson Laboratory is partnering with The Roux Institute at Northeastern to bring an engine of innovation, talent and economic growth to the Portland, Maine region.
Jackson Laboratory (JAX) Associate Professor Shuzhao Li uses high-resolution mass spectrometers to quantify metabolism, measuring thousands of small molecules in the body.
Distinguished biomedical engineer and researcher comes to The Jackson Laboratory
The Jackson Laboratory (JAX) has received $2.5 million from The Mark Foundation for Cancer Research to study in mice the influence of host genetics on response to immunotherapy. The goal of this project is to generate insights that will empower future decisions about the best treatments for cancer patients based on their genetic backgrounds.
JAX neuroscientist Erik Bloss develops high-resolution tools to study the wiring of neuronal circuits in normal brains and Alzheimer’s disease.
Researchers from JAX, UConn Health, and Connecticut Children’s sent genetically-engineered “Mighty Mice” to the International Space Station to learn about the effect of microgravity on muscle and bone loss.
The American Association for the Advancement of Science (AAAS) has elected Jackson Laboratory Professor Gary Churchill as an AAAS Fellow, one of the nation's highest scientific distinctions.
The Glioma Longitudinal Analysis (GLASS) Consortium characterized diffuse glioma cells both before and after therapy to characterize how they change and why this form of malignant brain cancer is so difficult to treat. The findings provide a foundation for further research and the opportunity for the clinical community to predict the effectiveness of newly developed treatments.
Human somatic cell genome editing is a promising treatment option for cardiovascular disorders, but concerns remain about the safety and efficacy of this therapeutic strategy.
STAT taps Jackson Laboratory postdoc Amy Dunn for 2019 class of future science superstars.
The Howard Hughes Medical Institute has made a three-year grant to support JAX-GE advanced courses for talented graduate students, postdoctoral fellows and early-career faculty who will be future leaders in biomedical research and education.
The Jackson Laboratory collaborates with researchers in China to further understand and harness the genetic and biological complexity of disease to improve human health
The National Institutes of Health have contracted with a JAX team led by Bill Skarnes, professor and director of cellular engineering, to generate a collection of engineered iPSC brain cell lines for the National Institute on Aging.
Genetically diverse research animal models are key to understanding complex diseases.
National Institute on Aging makes $6.8 million grant for JAX research in cognitive aging.
$7.9 million grant to JAX scientists extend an important testing program for age-retarding agents
The National Eye Institute has made a four-year grant totaling $2,144,828 for continued funding for The Jackson Laboratory's Eye Mutant Resource.
JAX, UConn researchers explore how patients’ microbiome, and risk of infection, change after time in a skilled nursing facility.
JAX researcher's obesity research is focused on how the food we eat changes our brains, and how those changes influence how much food we eat.
New research by JAX Assistant Professor Adam Williams, published in Science, points the way to more precise allergy testing as well as identifying new approaches for treating allergy.
The Jackson Laboratory announces the recipients of its 2019 JAX College Scholarship: Shannon O’Roak of Exeter, Maine; Joanna Idrovo of Torrington, Connecticut; and Monserath Mendoza of Sacramento, California.
The 8th annual JAXfit 5k walk/run took place Saturday, July 13 to raise awareness in the local community about addiction.
Two new mouse models created to study neurological developments in Snyder-Robinson Syndrome to advance global understanding of this rare disease.
Innovative AI technology captures mouse sleep and social behaviors for the study of their influence on drug intake and addiction.
JAX has teamed with Lovelace Biomedical, Exemplar Genetics, Iontox and the University of Pennsylvania to win a new $17M contract with the NIH to provide new tools for advancing cures of rare and neglected diseases.
A new study published in Nature sets a new precedent for understanding the development of type 2 diabetes, and it provides a trove of data for ongoing research.
Researchers say that harnessing a specific immune response to prevent inflammation could prevent insulin resistance, cardiovascular disease.
A recent study used multiple advanced technologies to dive deeper into the human genome than ever before to comprehensively characterize the structural variants present in three families, and what their functional consequences might be.
Research led by the UConn School of Medicine and JAX shows that senescence, a cellular aging process, is associated with an aggressive form of multiple sclerosis (MS). The finding explains a mechanism for MS disease progression as well as indicating a promising avenue for therapy development.
Continuing The Jackson Laboratory’s (JAX) commitment to making a difference in STEM education and developing future scientists, JAX was the Life Sciences Major sponsor for the 2019 Connecticut Science and Engineering Fair (CSEF).
High school students presented their original research and engineering project to a state-wide audience of peers and mentors, in competition for coveted state titles and more than $548,000 in scholarships and awards.
In addition to exploring antiviral lung immune function, The Cooperative Center on Human Immunology will also investigate changes brought about by two diseases: adult lung cancer and childhood asthma.
Emaly Piecuch, Ph.D. and Jufen Zhu, Ph.D. performed their dissertation research at The Jackson Laboratory for Genomic Medicine in Farmington, Connecticut under the supervision of JAX Professor Yijun Ruan.
A collaborative team from UConn and The Jackson Laboratory have characterized neuron diversity in the lateral hypothalamic area (LHA), a critical coordinator of fundamental behaviors in the brain. The results provide important clues for understanding LHA neural circuits and the potential development of targeted neuropsychiatric therapies.
$2.8 million federal grant to The Jackson Laboratory (JAX) to understand the aging-related genomic changes in immune cells that affect responses to flu vaccines.
Supported by a recent four-year, $2.3M grant from the National Institute of General Medical Sciences, Wei is looking to develop a method for chromatin interaction analysis in single nuclei, with single-molecule resolution.
Crown Bioscience selects JAX to distribute MS-NASH, a model that more closely mirrors human disease development.
JAX has signed a research agreement for up to $4.2 million with Sanofi to identify new targets to treat triple-negative breast cancer and ovarian carcinoma.
The Clinical Genomics Laboratory will participate as an NCI-MATCH designated laboratory, helping to connect potentially eligible cancer patients at NCI-MATCH sites with clinical trials.
A team led by Jackson Laboratory Professor Yijun Ruan, Ph.D., has developed a new method, called ChIA-Drop, that allows researchers to investigate 3D genomic structures with unprecedented precision and clarity.
Representatives from the Bangor Savings Bank visited JAX headquarters to present their gift of $100,000 toward the Charles E. Hewett, Ph.D., Leadership Excellence Fund.
JAX’s Stitzel Laboratory secures funding from the National Institute of Diabetes and Digestive and Kidney Diseases that will allow them to explore a new genomic region linked to type 2 diabetes, with hopes of establishing them as new targets for treatment.
JAX Professors Roel Verhaak and Ching Lau are leading research programs into glioblastoma with awards from the National Cancer Institute as part of a large national research consortium.
Recent research suggests long non-coding RNAs (lncRNAs) contribute to immune dysfunction, and JAX Assistant Professor Adam Williams is investigating the roles they may play in asthma.
Tom Ellis will oversee the human resources and safety functions for the Laboratory.
Supported by a grant from the U.S. Department of Defense, Elise Courtois is researching the genetic mechanisms underlying endometriosis, a painful disease with no non-surgical treatment.
A new genetically diverse mouse population is opening possibilities for translational research into Alzheimer’s disease that accurately recreates human disease symptoms and progression.
JAX announces several key milestones in China that will help to empower the Chinese biomedical research community.
Armed with new funding from the V Foundation, Olga Anczuków-Camarda is uncovering genetic changes in the breast, paving the road to early cancer detection and prevention.
Using computer models, researchers have identified a potential new therapy that would reduce the long-term side effects of radiation therapy in pediatric brain cancer patients.
Abbott will lead the development of financial strategies, plans, and budgets, as well as continue to guide JAX’s financial services team.
Clinicians, translational researchers, academics, clinical lab personnel, and even patients may choose between three levels of access to best suit their needs.
DSCAM interacts with other cell adhesion molecules to prevent their running amok.
NIH awards $3.5M to JAX under multi-institution Somatic Cell Genome Editing program.
The National Institute on Drug Abuse has made a $4M grant to JAX scientists to explore the roles of the microbiome and genetics in substance use disorders.
$2.8 million Department of Defense grant will fund JAX research defining gene-environment interactions of islet resilience and type 2 diabetes
Postdoctoral Associate Eunhee Yi has been awarded a $100,000 fellowship from the American Brain Tumor Association to discover how glioblastoma becomes so aggressive.
New research shows that a cytokine signature found in certain kinds of breast cancer cells can not only serve as a diagnostic tool for HER2-negative cancers but also offer an effective treatment target.
Next-generation anti-infectives designed to address the evolving issue of drug resistance.
A new approach to treating some leukemias could deliver a one-two punch to the cancer cells without harming normal tissue.
When an otherwise harmless fungus like Aspergillus fumigatus invades the lungs of people with compromised immune systems, it can cause severe respiratory problems. A new NIH grant will employ specialized mathematical and computer modeling to improve understanding of our biological defense system.
New five-year, $2.2M outstanding investigator grant to Mingyang Lu will support systems biology algorithm approach.
Travis Hinson, M.D., has received more than $2 million from the National Institutes of Health National Heart, Lung, and Blood Institute to study the mechanisms responsible for a serious and often fatal heart condition.
New $3.8M National Institute on Aging grant will fund JAX studies of hypothalamic dysfunction in Alzheimer’s.
The Jackson Laboratory has announced the promotion of Auro Nair, Ph.D., to Executive Vice President and Kenneth Fasman, Ph.D., to Senior Vice President for Research.
Indiana University-Jackson Laboratory MODEL-AD Center addresses critical need for precision animal models for Alzheimer’s research.
Inheriting a specific genetic variant, APOEε4, is linked with 15-20 percent rise in risk of developing Alzheimer’s, with at least 20 other genes implicated. JAX researchers are studying how APOEε4 risk depends on other genes, in mice with a wide variety of genetic backgrounds.
The event kicks off The Jackson Laboratory's initiative to make Bar Harbor, Maine dementia-friendly.
Gareth Howell named Diana Davis Spencer Foundation Chair for Glaucoma Research
June is Alzheimer’s & Brain Awareness Month, a time dedicated to increasing public awareness of Alzheimer’s disease, available resources and how you can get involved to support the cause.
JAX volunteers in three states volunteer to help families impacted by Alzheimer's disease.
A JAX research team led by Charles Lee has identified six significant copy number variations that are unique to patients with a severe birth defect.
A research team led by Chia-lin Wei is using technology to more easily detect and classify important types of difficult-to-find genomic alterations, known as structural variants.
Judith and Anthony Evnin, Ph.D., are giving $1.5 million to JAX to establish the Evnin Family Endowed Chair in Alzheimer’s Research. Catherine Kaczorowski, Ph.D., a JAX neuroscientist who is taking a bold approach to combat Alzheimer’s, has been appointed chairholder.
$10,000 JAX College Scholarship awarded to Norwich student.
New research is providing a better understanding of the processes underlying cell-to-cell differences within glioblastoma tumors — a crucial finding because these differences contribute to therapy resistance.
A Jackson Laboratory (JAX) research team led by Assistant Professor Duygu Ucar is among 85 teams to receive funding from the Chan Zuckerberg Initiative DAF, an advised find of Silicon Valley Community Foundation, to participate in the Human Cell Atlas project, a global, collaborative, multidisciplinary effort to catalog all the cells in the healthy human body.
First global online catalog of Patient-Derived Xenograft models helps cancer researchers save valuable time.
Michael Stitzel, Ph.D., a Jackson Laboratory assistant professor, is the senior author of a paper in the American Journal of Human Genetics identifying new genetic clues to type 2 diabetes mechanisms.
The JAX/Tufts CTSI collaboration will strengthen and expand research and training programs in clinical and translational science.
Honey Reddi was among the winners at the Connecticut Technology Council’s 2018 annual Women of Innovation Awards Gala in Plantsville, Connecticut, March 28.
The Alzheimer’s Association has awarded a three-year research fellowship to Amy Dunn, Ph.D., a postdoctoral associate in the Kaczorowski lab, for her studies of how genetics and diet interact to determine risk for Alzheimer’s disease.
As part of our commitment to make a difference in the communities where we live and work, The Jackson Laboratory (JAX) was a proud sponsor of the 70th Annual Connecticut Science and Engineering Fair (CSEF) that took place March 12-17 at Quinnipiac University.
Katy Longley will be promoted to executive vice president (EVP) and chief operating officer (COO) of the non-profit biomedical research institute.
The members of the American Association for Cancer Research have elected Jackson Laboratory President and CEO Edison T. Liu, M.D. to serve on the AACR Board of Directors for the 2018-2021 term.
JAX Professor Mary Ann Handel has been recognized by her peers for a career of science and service.
An Alzheimer's awareness event in Bangor was held to address the complexities of Alzheimer’s disease, to raise overall awareness, and to lend human voices to an immense public health problem.
Beginning his new role in March, Ryan will provide leadership and direction for all legal affairs of The Jackson Laboratory, including managing the legal department.
Maine Technology Institute awards Maine Technology Asset Funds to support Phase 2 of mouse vivarium construction.
Jackson Laboratory scientist conducts large-scale survey of cells from prediabetic, diabetic and normal patients to discover new treatments.
New funding and partnerships are helping JAX’s Molly Bogue accelerate progress in addiction research.
The Naggert lab has identified a genetic modifier that prevents the fragmentation of the external limiting membrane in two different mouse models models of enhanced S-cone syndrome and other diseases of the retina.
Single-cell characterization of non-myocyte heart cells offers new insights into the structure and function of the cardiac cellular landscape, including sex-based differences.
LuAnn Ballesteros has been promoted to vice president, external and government affairs, joining The Jackson Laboratory’s senior management team.
JAX Assistant Professor Catherine Kaczorowski, Ph.D., will receive a Young Investigator Award from the International Behavioural and Neural Genetics Society (IBANGS).
A grant from the National Human Genome Research Institute to JAX Assistant Professor Albert Cheng, Ph.D., will fund the creation of a molecular “toolkit” to explore the effects of epigenetic modifications
New minimal information standard makes patient-derived xenograft (PDX) models easy to find, access, integrate and reuse.
JAX, Rockefeller research team shows mice lacking Daple show developmental defects in hair cells and bundles.
New research has important implications for vaccine delivery, as the usual method, intramuscular injection, is likely not the most effective way to trigger our immune systems.
JAX online Disease Navigator tool will enable heart disease researchers to access genomic data shared by humans and animal models.
Chang studies cell metabolism in tumor and immune cells, with the aim of developing new treatment approaches for cancers and immunologic diseases.
New website provides unified access to comparative genetics and genomics data.
Research at Nationwide Children’s and The Jackson Laboratory will provide new strategies to protect young children from invasive infections.
National Cancer Institute awards $2M grant to fund joint PDX data center to integrate, share and analyze cancer treatment data for research community.
Five-year, $25 million grant distributed among nine research institutes in the United States.
Research in skin microorganisms could lead to better therapies for skin and infectious diseases.
Ke focuses on the role of RNA function in health and disease, including cancer.
Grant to JAX Professor Derya Unutmaz, M.D., part of multi-institutional research effort to understand and treat Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Research by Krish Kizhatil, Ph.D., could lay the groundwork for identifying more effective glaucoma treatments.
Mouse models for acute myeloid leukemia are available with a wide range of genetic mutations and growth profiles more closely mimic the human population.
Catherine Kaczorowski will use National Institute on Aging funding to seek targets for treatment and prevention of Alzheimer’s disease.
Jackson Laboratory (JAX) Assistant Professor Catherine Kaczorowski, Ph.D., has been recognized by The Glenn Foundation for Medical Research for her efforts toward gaining a better understanding of cognitive aging.
JAX scientists to explore genetic mechanisms in retinitis pigmentosa, other heritable retinal disorders.
New JAX assistant professor Ryan Tewhey, PhD., explores genetic variants that affect gene regulation.
BJ Bormann has joined nonprofit biomedical research institution, The Jackson Laboratory, as vice president, translational science and network alliances.
Zhengqing Ouyang will analyze role of RNA structure in neurological disorders, cancer and other diseases.
Research by Yanjiao Zhou will explore microbiome mechanisms leading to MS and preventive potential of intermittent fasting.
Research by Duygu Ucar will explore why our immune system deteriorates as we age.
A new five-year federal research grant totaling $3,322,009 to JAX Associate Professor Greg Cox will fund studies of a new mouse model for amyotrophic lateral sclerosis (ALS).
New collaboration expands access to leading-edge research capabilities to find new treatments for life-threatening diseases.
A JAX-led research team detects gene expression patterns distinct from those of the surrounding immune cells, and characterizes the effects of chemotherapy and radiation treatments.
Two subsets of dendritic cells work together to activate T cells against a virus, reports a research team led by JAX Professor Karolina Palucka
The sex of animals frequently has an effect in biomedical research and therefore should be considered in the study of science, report an international team of scientists including The Jackson Laboratory.
Crown Bioscience and The Jackson Laboratory have announced an agreement to improve the development and accessibility of innovative research models and preclinical services to the global biomedical research community.
Christine Beck, Ph.D., a genomics expert in transposable elements and their impact on human disease, will join The Jackson Laboratory for Genomic Medicine and UConn Health as their fifth joint-appointed faculty.
The prestigious 2017 ELSI Congress was hosted by UConn Health and The Jackson Laboratory for Genomic Medicine June 5-7 in Farmington, Conn.
Discoveries in JAX-founded Collaborative Cross, Diversity Outbred populations show value of multi-parent model organism systems
JAX researchers, collaborators block B-cell AID, prevent diabetes in non-obese diabetic mice
The institution signed on 315 employees and received $12.7 M in grants in 2016.
A five-year National Institute on Aging grant to JAX Assistant Professor Catherine Kaczorowski will fund genomic studies of healthy aging and Alzheimer’s disease.
Genomics and Society: Expanding the ELSI Universe is a three-day conference on the myriad issues that spring from the ethical, legal and social implications of genomic research.
In a paper published in Aging Cell, Jackson Laboratory Assistant Professor Ron Korstanje, Ph.D., Postdoctoral Fellow George Sutphin, Ph.D., and colleagues discovered 46 novel longevity-related genes and identified three genes that especially warrant further study.
Currently there are no effective cures for age-related macular degeneration and other heritable retinal diseases.
A select group of students will soon join the front lines of cutting-edge genetics research thanks to a new academic collaboration between The Jackson Laboratory and College of the Atlantic.
Specific genetic mutations in Charcot-Marie-Tooth disease that worsen peripheral nerve damage could be a helpful biomarker for predicting the severity of a given case of CMT.
Winners will represent Maine at prestigious International Science Fair; scholarships from The University of Maine, College of the Atlantic, and University of Southern Maine awarded to promising high school scientists.
It's time to update the old “bench-to-bedside” shorthand, researchers at JAX, NHGRI and institutions across the U.S. declare.
Single-cell signatures of colorectal tumors can provide more targeted diagnosis and treatment
The Maine Cancer Genomics Initiative has accomplished key milestones toward its mission of partnering with clinical institutions and oncology practices in Maine to help cancer patients across the state.
Two grants from the U.S. Department of Defense totaling $2.8 million will support Jackson Laboratory (JAX) research in one of the most deadly forms of breast cancer, known as triple-negative breast cancer.
A two-year NIH grant to JAX totaling $455,000 will support research to improve the accuracy and efficiency of CRISPR-Cas9 genome editing.
Auro Nair, Ph.D., has been promoted to president of JAX® Mice, Clinical and Research Services.
M.D. Anderson Cancer Center and JAX Genomic Medicine begin clinical study using JAX ActionSeq Plus™ to identify additional treatment options for patients with cancers of unknown primary.
New research shows that simply adding vitamin B3 to the drinking water of mice predisposed to glaucoma can prevent the debilitating eye disease.
Se-Jin Lee, M.D., Ph.D., will begin his role as Presidential Distinguished Professor at UConn School of Medicine and professor at The Jackson Laboratory this summer.
The National Human Genome Research Institute has awarded a grant totaling $6,727,904 over four years to JAX Professor Yijun Ruan to launch a center for the 3-D mapping of the human and mouse genomes.
Cancer cells hijack a mechanism that enables stem cells and germ cells to continue dividing, by reactivating telomerase. A research team led by JAX Professor Roel Verhaak reports on the discovery that, in about 35 percent of cancers, TERT promoter methylation is the key to cancer cells' success in maintaining telomeres and surviving.
Genomics pioneer and bioinformatics expert Mark Adams, Ph.D. will enhance the The Jackson Laboratory’s large-scale microbiome initiatives.
Dozens of employees and dignitaries braved the frigid temperatures today to celebrate the ceremonial “topping out” of the new Center for Biometric Analysis at The Jackson Laboratory.
Grant funding will support Basile Tarchini’s studies into how defects in the architecture of sensory cells perceiving sounds cause hereditary hearing deficits.
Gregory Leet will lead global development, communications and trustee relations at JAX.
Edison T. Liu, M.D. of The Jackson Laboratory (JAX) has been named a Fellow of the American Association for the Advancement of Science (AAAS).
Three Connecticut research institutions are partnering with a prestigious counterpart in Israel to fill a research void that exists in the area of metabolic diseases, such as obesity and diabetes, which affect billions of people worldwide.
Caribou has granted JAX non-exclusive worldwide rights to use its CRISPR-Cas9 intellectual property to create genetically engineered mice for research purposes.
Kaczorowski is a neuroscientist who works to identify early causative events that underlie cognitive deficits associated with normal aging and Alzheimer’s disease, has been appointed a Jackson Laboratory assistant professor.
Baker explores the genetic and molecular regulatory system controlling the location and rate of meiotic recombination, the process that generates new genetic variation in sexually reproducing organisms.
Comprehensive suite of genome editing technologies will enable custom-made mouse models for studying human disease.
Joint appointment with Connecticut Children's Medical Center and the UConn School of Medicine will foster development of new genomic technologies for pediatric brain and bone cancers, create advanced treatments for patients.
A new grant from the National Institute of General Medical Sciences to Jackson Laboratory Associate Professor Greg Carter, Ph.D., will fund the development of new computational tools to analyze vast amounts of genomic data to understand how multiple genes interact in complex diseases.
Grant provides $25 million to develop new treatments, future therapies based on precision modeling.
The National Institute on Aging (NIA) has awarded a four-year, $2,348,313 grant to Jackson Laboratory (JAX) Professor Jacques Banchereau, Ph.D., to develop better prevention and treatment strategies for pneumococcal pneumonia in elderly people, who are at elevated risk for illness and death from the disease.
New research finds that of 1,751 genes characterized by the International Mouse Phenotyping Consortium to date, nearly one third are essential for life.
Jacqueline White, Ph.D., a scientific manager who has led large-scale laboratory animal operations in the United Kingdom, will direct The Jackson Laboratory’s (JAX) new Center for Biometric Analysis (CBA), now under construction on the institution’s Bar Harbor, Maine, headquarters campus.
JAX has entered into a sponsored research agreement with bioMérieux USA to develop more precise diagnostics for pathogens and their antimicrobial resistances in infectious diseases.
A grant of $225,000 from the Maximilian E. & Marion O. Hoffman Foundation, Inc., will provide funding to support a postdoctoral fellow at The Jackson Laboratory.
The Jackson Laboratory and Shoreline Biome are partnering to develop new ways to study the microbiome and develop new diagnostic approaches for disease-causing pathogens.
The spleen’s mechanisms for responding to blood-borne antigens mirror those in immune responses in other sites of the body, and could potentially be harnessed to prevent life-threatening immune responses in patients requiring frequent blood transfusions.
Experts say the success of precision medicine — developing therapies based on an individual patient’s unique genetic profile and lifestyle — will depend on continued research into basic biology and disease mechanisms using animal models.
New JAX resource will accelerate the creation, distribution and use of high-priority mouse models for Charcot-Marie-Tooth research.
The Jackson Laboratory has named medical oncologist Jens Rueter, M.D., to the newly created position of medical director for the Maine Cancer Genomics initiative.
Next Gen Ph.D.: A Guide to Career Paths in Science, a new book by Melanie V. Sinche, director of education at The Jackson Laboratory (JAX) for Genomic Medicine, provides tips and strategies for finding rewarding jobs in the sciences.
Martin F. Pera, Ph.D., is a leading stem cell researcher with interests in neuroscience and regenerative medicine. He will join The Jackson Laboratory in January 2017.
The discovery offers a potential therapeutic target for certain inflammatory disorders, such as asthma, Churg-Strauss syndrome and hypereosinophilic syndrome, that are characterized by abnormal myeloid cell lifespan.
We use cookies to personalize our website and to analyze web traffic to improve the user experience. You may decline these cookies although certain areas of the site may not function without them. Please refer to our privacy policy for more information.